Bp PLC Horizon Therapeutics Public LTD CO Transaction History

Bp PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$91.91 - $110.37 $479,034 - $575,248	-5,212 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$86.24 - $95.92 $203,612 - $226,467	-2,361 Reduced 31.18%	5,212 $488,000
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $199,902 - $265,720	-2,783 Reduced 26.87%	7,573 $697,000
Q4 2020 Feb 08, 2021	BUY	$67.0 - $84.39 $693,852 - $873,942	10,356 New	10,356 $758,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.